Share Email Print

Proceedings Paper

Inhibition of vascular smooth muscle cells by photodynamic therapy is effective and depends on intracellular Photofrin
Author(s): Mohammed S. Sobeh; Philip Chan; Robert J. Ham; Frank W. Cross M.D.
Format Member Price Non-Member Price
PDF $17.00 $21.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Photodynamic therapy (PDT) is a promising treatment for vascular restenosis. Determining the site of the photosensitiser responsible for cytotoxicity during PDT is essential for planning treatment strategies. Vascular smooth muscle cells (VSMCs) were cultured from 6 individuals using substrate attached explant techniques and transferred into microtitire plates at 50,000 cells/well. Cells were arranged in 3 groups; the first group was incubated with 2 (mu) gml-1 of Photofrin for 48 hours, followed by polychromatic light illumination of 3 Jcm-2. In the second group the extracellular Photofrin was removed by washing cells just prior to illumination, and in the third group Photofrin was only added immediately prior to illumination. Results are expressed as mean percentage cell survival+/- SEM. Cells were minimally affected by extracellular Photofrin alone (91.9+/- 10.7). Photofrin in the intracellular and (intra+extracellular) compartments reduced VSMCs survival to (7.3+/- 4.9) and (8.8+/- 2.6). The mechanism of ablation appears to be due to activation of the intracellular rather than residual Photofrin in the extracellular medium

Paper Details

Date Published: 12 July 1994
PDF: 3 pages
Proc. SPIE 2130, Diagnostic and Therapeutic Cardiovascular Interventions IV, (12 July 1994); doi: 10.1117/12.179928
Show Author Affiliations
Mohammed S. Sobeh, The Royal London Hospital (United Kingdom)
Philip Chan, The Royal London Hospital (United Kingdom)
Robert J. Ham, The Royal London Hospital (United Kingdom)
Frank W. Cross M.D., The Royal London Hospital (United Kingdom)

Published in SPIE Proceedings Vol. 2130:
Diagnostic and Therapeutic Cardiovascular Interventions IV
George S. Abela M.D., Editor(s)

© SPIE. Terms of Use
Back to Top